R&D | January 28, 2026
Eastman & Kolmar Korea join forces to deliver biodegradable beauty breakthroughs
The collaboration will center on expanding access to Eastman’s Esmeri technology
The collaboration will center on expanding access to Eastman’s Esmeri technology
The new functionality complements Parse’s existing Evercode immune products
This innovation enhances viral stability, preserves potency, and reduces allergic reactions and antigen crystallisation-related issues
The goal of the agreement is to advance cell and gene therapy accessibility by enabling scalable and efficient cell therapy manufacturing
The Phase 1 single and multiple ascending dose study is set to begin dosing in early Q1 2026
Galenicum will oversee development, manufacturing and supply, while Lupin will handle regulatory submissions, approvals, and commercialization and distribution of Semaglutide across 23 countries globally
Sofetabart mipitecan is a novel folate receptor alpha (FR?) antibody-drug conjugate (ADC) leveraging proprietary linker technology and an exatecan payload to target tumor cells
Stevens succeeds Milton Boyer, who has stepped down as CEO but will remain closely involved with the business as an independent member of Kindeva’s Board of Directors
The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
The feature will be available across all Max Healthcare facilities, offering patients consistent and convenient access to services nationwide
Subscribe To Our Newsletter & Stay Updated
